Search for: "SANOFI-PHARMACEUTICALS, INC."
Results 61 - 80
of 214
Sort by Relevance
|
Sort by Date
1 Apr 2016, 1:25 pm
Here, plaintiffs were sophisticated investors who were familiar with the pharmaceutical industry. [read post]
15 Mar 2016, 5:09 pm
Sanofi,1 the Second Circuit interpreted and applied for the first time the Supreme Court’s decision in Omnicare Inc. v. [read post]
15 Mar 2016, 9:00 am
On March 4, 2016, the Second Circuit affirmed the dismissal of two related securities actions against Sanofi Pharmaceuticals, its predecessor Genzyme Corporation, and three company executives (collectively, “Sanofi”). [read post]
31 Dec 2015, 5:12 am
Ortho-McNeil-Janssen Pharmaceuticals, Inc., ___ F.3d ___, 2015 WL 8538119 (6th Cir. [read post]
22 Oct 2015, 8:42 am
IMS Health, Inc., 131 S. [read post]
29 Jul 2015, 10:00 pm
LLC and Regeneron Pharmaceuticals, Inc. filed a petition for Inter Partes Review (IPR) of the “Cabilly II” patent, U.S. [read post]
14 May 2015, 4:00 am
In Eli Lilly Canada Inc. v. [read post]
18 Jan 2015, 9:06 pm
LLC; Aventis Pharma S.A.; Sanofi • Defendant: Breckenridge Pharmaceutical, Inc. [read post]
21 Nov 2014, 4:00 am
Over the past few years the pharmaceutical marketplace has seen an increase in patent “re-litigation” (where a patentee is involved in a second case against another generic). [read post]
18 Nov 2014, 11:16 am
Indeed, the government has used this ban as the basis for a creeping administrative takeover of pharmaceutical and medical device public relations practices. [read post]
16 Nov 2014, 4:00 am
Pharmaceuticals: Delayed Market EntryApotex Inc. v. [read post]
2 Nov 2014, 8:58 pm
• Defendants: Sanofi; Aventisub LLC; Regeneron Pharmaceuticals Inc. [read post]
18 Jul 2014, 11:55 am
Wyeth Pharmaceuticals, Inc., 2008 WL 7136137 (Ala. [read post]
7 Jul 2014, 11:34 am
Originally, Amphastar Pharmaceuticals, Inc. and Sanofi-Aventis S.A. battled it out in 2008 in a patent dispute over Sanofi-Aventis’s anticoagulant drug. [read post]
17 Jun 2014, 6:15 pm
Inc., at *4-5 (internal citations omitted) (text added).Endo Pharmaceuticals, Inc. [read post]
15 Jun 2014, 8:46 pm
.; Glenmark Generics Inc., USA • Defendant: Ferring, B.V. [read post]
30 Apr 2014, 10:00 pm
Glenmark Pharmaceuticals Inc., USA, addresses several interesting issues, but is most likely to be cited by other patent holders for its affirmance of the jury verdict that upheld the Tarka patent at issue. [read post]
24 Apr 2014, 9:59 pm
By Michael Greenfield -- On April 21, 2014, a Federal Circuit panel reiterated its interpretation and application to the chemical arts of the KSR obviousness standard. [read post]
22 Apr 2014, 7:41 am
In 2007 the defendants Glenmark Pharmaceuticals Inc. and Glenmark Pharmaceuticals Ltd. [read post]
19 Apr 2014, 8:50 am
Sanofi-Aventis, Annual Report (Form 20-F), at 61 (Mar. 7, 2008); Teva Pharmaceutical Industries Ltd., Annual Report (Form 20-F), at 20 (Mar. 31, 2001). [read post]
